Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Results of a multicenter SCAPP1 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples